NVCR logo

NovoCure Limited (NVCR) Depreciation And Amortization

Annual D&A

$11.23 M
+$266.00 K+2.43%

December 31, 2024

Summary

Performance

1-Year Change

+2.43%

3-Year Change

+9.6%

5-Year Change

+32.8%

15-Year Change

+46.35%

NVCR Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

73.08%
NVCR annual depreciation & amortization is higher than 73.08% of companies in Healthcare sector

High & Low

All-time High

$11.23 M
NVCR annual depreciation & amortization is currently at an all-time high

3-Year Low

$10.25 M
NVCR annual depreciation & amortization is currently +9.60% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
NVCR previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
NVCR next annual earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$775.72 M
NVCR annual total expenses is $775.72 million

Annual Operating Expenses

$638.53 M
NVCR annual total operating expenses is $638.53 million

Annual Cost Of Goods Sold

$137.18 M
NVCR annual cost of goods sold is $137.18 million

Annual Interest Expense

$10.34 M
NVCR annual interest expense is $10.34 million

Quarterly D&A

$3.10 M
+$646.00 K+26.28%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

+16.39%

5-Year Change

+25.82%

NVCR Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

72.96%
NVCR quarterly depreciation & amortization is higher than 72.96% of companies in Healthcare sector

High & Low

All-time High

$3.10 M
NVCR quarterly depreciation & amortization is currently at an all-time high

3-Year Low

$2.46 M
NVCR quarterly depreciation & amortization is currently +26.28% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
NVCR previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 2, 2025
NVCR next earnings announcement is scheduled for May 2, 2025

Related metrics

Quarterly Total Expenses

$224.57 M
NVCR quarterly total expenses is $224.57 million

Quarterly Operating Expenses

$191.10 M
NVCR quarterly total operating expenses is $191.10 million

Quarterly Cost Of Goods Sold

$33.47 M
NVCR quarterly cost of goods sold is $33.47 million

Quarterly Interest Expense

-
NVCR quarterly interest expense value is unknown

TTM D&A

$11.23 M
+$381.00 K+3.51%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

+9.6%

5-Year Change

+32.8%

NVCR TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

72.21%
NVCR TTM depreciation & amortization is higher than 72.21% of companies in Healthcare sector

High & Low

All-time High

$11.23 M
NVCR TTM depreciation & amortization is currently at an all-time high

3-Year Low

$10.25 M
NVCR TTM depreciation & amortization is currently +9.60% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
NVCR previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 2, 2025
NVCR next earnings announcement is scheduled for May 2, 2025

Related metrics

Annual Total Expenses

$775.72 M
NVCR annual total expenses is $775.72 million

Annual Operating Expenses

$638.53 M
NVCR annual total operating expenses is $638.53 million

TTM Cost Of Goods Sold

$137.18 M
NVCR TTM cost of goods sold is $137.18 million

TTM Interest Expense

-
NVCR TTM interest expense value is unknown

NVCR Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+2.4%0.0%0.0%
3 y3 years+9.6%+16.4%+9.6%
5 y5 years+32.8%+25.8%+32.8%

NVCR Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+9.6%at high+26.3%at high+9.6%
5 y5-yearat high+32.8%at high+64.4%at high+33.5%
alltimeall timeat high+823.9%at high+492.4%at high+2044.1%

NovoCure Limited Depreciation And Amortization History

DateAnnualQuarterlyTTM
Dec 2024
$11.23 M(+2.4%)
$3.10 M(+26.3%)
$11.23 M(+3.5%)
Sep 2024
-
$2.46 M(-14.0%)
$10.85 M(-3.1%)
Jun 2024
-
$2.86 M(+1.5%)
$11.20 M(+1.2%)
Mar 2024
-
$2.81 M(+3.4%)
$11.06 M(+0.8%)
Dec 2023
$10.97 M(+3.2%)
$2.72 M(-2.9%)
$10.97 M(+0.2%)
Sep 2023
-
$2.80 M(+3.0%)
$10.95 M(+1.3%)
Jun 2023
-
$2.72 M(-0.0%)
$10.80 M(+0.6%)
Mar 2023
-
$2.72 M(+0.8%)
$10.74 M(+1.1%)
Dec 2022
$10.62 M(+3.6%)
$2.70 M(+1.5%)
$10.62 M(+0.3%)
Sep 2022
-
$2.66 M(+0.2%)
$10.59 M(-0.7%)
Jun 2022
-
$2.65 M(+1.7%)
$10.66 M(+1.7%)
Mar 2022
-
$2.61 M(-2.1%)
$10.49 M(+2.3%)
Dec 2021
$10.25 M(+12.0%)
$2.67 M(-2.5%)
$10.25 M(+1.9%)
Sep 2021
-
$2.73 M(+10.2%)
$10.06 M(+5.7%)
Jun 2021
-
$2.48 M(+4.6%)
$9.51 M(-1.3%)
Mar 2021
-
$2.37 M(-4.2%)
$9.63 M(+5.3%)
Dec 2020
$9.15 M(+8.2%)
$2.47 M(+13.0%)
$9.15 M(+0.1%)
Sep 2020
-
$2.19 M(-15.9%)
$9.14 M(+2.9%)
Jun 2020
-
$2.60 M(+37.8%)
$8.89 M(+5.6%)
Mar 2020
-
$1.89 M(-23.5%)
$8.42 M(-0.5%)
Dec 2019
$8.46 M
$2.47 M(+27.7%)
$8.46 M(+3.2%)
DateAnnualQuarterlyTTM
Sep 2019
-
$1.93 M(-9.4%)
$8.20 M(-4.4%)
Jun 2019
-
$2.13 M(+10.5%)
$8.58 M(-1.8%)
Mar 2019
-
$1.93 M(-12.5%)
$8.73 M(-3.0%)
Dec 2018
$9.01 M(+17.3%)
$2.21 M(-4.6%)
$9.01 M(+0.6%)
Sep 2018
-
$2.31 M(+1.0%)
$8.95 M(+3.0%)
Jun 2018
-
$2.29 M(+3.8%)
$8.70 M(+5.8%)
Mar 2018
-
$2.20 M(+2.3%)
$8.22 M(+7.1%)
Dec 2017
$7.68 M(+35.8%)
$2.15 M(+4.9%)
$7.68 M(+7.9%)
Sep 2017
-
$2.05 M(+13.4%)
$7.11 M(+7.6%)
Jun 2017
-
$1.81 M(+9.1%)
$6.61 M(+6.5%)
Mar 2017
-
$1.66 M(+4.5%)
$6.21 M(+9.9%)
Dec 2016
$5.65 M(+79.3%)
$1.59 M(+2.3%)
$5.65 M(+8.5%)
Sep 2016
-
$1.55 M(+10.4%)
$5.21 M(+14.5%)
Jun 2016
-
$1.41 M(+27.6%)
$4.55 M(+21.9%)
Mar 2016
-
$1.10 M(-3.9%)
$3.73 M(+18.4%)
Dec 2015
$3.15 M(+60.7%)
$1.15 M(+28.6%)
$3.15 M(+57.3%)
Sep 2015
-
$893.00 K(+51.9%)
$2.00 M(+80.3%)
Jun 2015
-
$588.00 K(+12.2%)
$1.11 M(+112.2%)
Mar 2015
-
$524.00 K
$524.00 K
Dec 2014
$1.96 M(+61.3%)
-
-
Dec 2013
$1.22 M
-
-

FAQ

  • What is NovoCure Limited annual depreciation & amortization?
  • What is the all time high annual D&A for NovoCure Limited?
  • What is NovoCure Limited annual D&A year-on-year change?
  • What is NovoCure Limited quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for NovoCure Limited?
  • What is NovoCure Limited quarterly D&A year-on-year change?
  • What is NovoCure Limited TTM depreciation & amortization?
  • What is the all time high TTM D&A for NovoCure Limited?
  • What is NovoCure Limited TTM D&A year-on-year change?

What is NovoCure Limited annual depreciation & amortization?

The current annual D&A of NVCR is $11.23 M

What is the all time high annual D&A for NovoCure Limited?

NovoCure Limited all-time high annual depreciation & amortization is $11.23 M

What is NovoCure Limited annual D&A year-on-year change?

Over the past year, NVCR annual depreciation & amortization has changed by +$266.00 K (+2.43%)

What is NovoCure Limited quarterly depreciation & amortization?

The current quarterly D&A of NVCR is $3.10 M

What is the all time high quarterly D&A for NovoCure Limited?

NovoCure Limited all-time high quarterly depreciation & amortization is $3.10 M

What is NovoCure Limited quarterly D&A year-on-year change?

Over the past year, NVCR quarterly depreciation & amortization has changed by $0.00 (0.00%)

What is NovoCure Limited TTM depreciation & amortization?

The current TTM D&A of NVCR is $11.23 M

What is the all time high TTM D&A for NovoCure Limited?

NovoCure Limited all-time high TTM depreciation & amortization is $11.23 M

What is NovoCure Limited TTM D&A year-on-year change?

Over the past year, NVCR TTM depreciation & amortization has changed by $0.00 (0.00%)